Y-mAbs Therapeutics (YMAB) Earnings Date, Estimates & Call Transcripts $4.35 -0.10 (-2.25%) Closing price 04/10/2025 04:00 PM EasternExtended Trading$4.33 -0.02 (-0.44%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics Earnings Summary Upcoming Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Mar. 4) -$0.13 Actual EPS (Mar. 4) -$0.15 Missed By -$0.02 Actual Revenue (Mar. 4) $26.50MY-mAbs Therapeutics announced Q4 2024 earnings on March 4, 2025, reporting an EPS of -$0.15, which missed analysts' consensus estimates of -$0.13 by $0.02. Quarterly revenue was reported to be $26.50 million, below analyst estimates of $26.70 million. With a trailing EPS of -$0.67, Y-mAbs Therapeutics' earnings are expected to grow next year, from ($0.65) to ($0.59) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)YMAB Upcoming EarningsY-mAbs Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Y-mAbs Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Y-mAbs Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataYMAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.YMAB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Y-mAbs Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.23-$0.17-$0.20Q2 20253-$0.27-$0.06-$0.19Q3 20253-$0.26-$0.07-$0.17Q4 20253-$0.25-$0.07-$0.17FY 202511($1.01)($0.37)($0.73) Remove Ads Y-mAbs Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------3/4/2025Q4 2024-$0.13-$0.15 -$0.02-$0.15$26.70M$26.50M11/8/2024Q3 2024-$0.14-$0.16 -$0.02-$0.16$23.38M$18.46M8/12/2024Q2 2024-$0.13-$0.21 -$0.08-$0.21$23.09M$22.80M5/7/2024Q1 2024-$0.12-$0.15 -$0.03-$0.15$22.06M$19.93M2/29/2024Q4 2023-$0.19-$0.02+$0.17-$0.02$21.72M$23.36M11/13/2023Q3 2023-$0.16-$0.18 -$0.02-$0.18$20.56M$20.45M8/10/2023Q2 2023-$0.24-$0.14+$0.10-$0.14$19.04M$20.75M5/8/2023Q1 2023-$0.31-$0.15+$0.16-$0.15$15.55M$20.30M Y-mAbs Therapeutics Earnings - Frequently Asked Questions When is Y-mAbs Therapeutics's earnings date? Y-mAbs Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on YMAB's earnings history. What guidance has Y-mAbs Therapeutics issued on next quarter's earnings? Y-mAbs Therapeutics issued an update on its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $75.0 million-$90.0 million, compared to the consensus revenue estimate of $105.8 million. Did Y-mAbs Therapeutics beat their earnings estimates last quarter? In the previous quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) missed the analysts' consensus estimate of ($0.13) by $0.02 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. YMAB's actual earnings. How can I listen to Y-mAbs Therapeutics's earnings conference call? The conference call for Y-mAbs Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Y-mAbs Therapeutics's conference call transcript? The conference call transcript for Y-mAbs Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Y-mAbs Therapeutics generate each year? Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded annual revenue of $87.69 million. How much profit does Y-mAbs Therapeutics generate each year? Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded net income of -$21.43 million. YMAB has generated -$0.67 earnings per share over the last four quarters. What is Y-mAbs Therapeutics's EPS forecast for next year? Y-mAbs Therapeutics's earnings are expected to grow from ($0.65) per share to ($0.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies Arcus Biosciences Earnings Vir Biotechnology Earnings Mineralys Therapeutics Earnings Phibro Animal Health Earnings Spyre Therapeutics Earnings Nurix Therapeutics Earnings Zymeworks Earnings Gyre Therapeutics Earnings Day One Biopharmaceuticals Earnings Anavex Life Sciences Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:YMAB) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy YMAB Stock Free YMAB Stock Alerts